Heart Valve Devices | China | 2016 | Market Analysis
The Chinese heart valve device market will experience robust growth through 2024, driven by an aging population and the adoption of THV devices.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for heart valve devices in China across a 10-year period.
THV devices represent the most significant growth opportunity in the Chinese heart valve device market.
What types of patients will be eligible for these procedures?
Will TAVR enjoy the same level of success it has seen in the US and Europe?
When are the major competitors slated to enter the market?
The Chinese heart valve device market is characterized by large regional disparities.
Where are the largest regional markets currently?
Where are the fastest-growing regional markets?
What cities and hospitals perform the most heart valve procedures?
Where are local competitors concentrated?
Reform of the Chinese health care landscape is occurring rapidly.
What is the status and future of government health insurance programs?
How will economic and social welfare reforms affect the growth of the heart valve device market?
The disease epidemiology of China differs from that of Western countries.
How will these differences affect the choice between tissue and mechanical heart valves?
Which heart valves are most likely to be replaced or repaired in China?
